Étienne Dumont

2.5k total citations · 1 hit paper
118 papers, 1.9k citations indexed

About

Étienne Dumont is a scholar working on Aerospace Engineering, Oncology and Molecular Biology. According to data from OpenAlex, Étienne Dumont has authored 118 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Aerospace Engineering, 24 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Étienne Dumont's work include Rocket and propulsion systems research (36 papers), Spacecraft and Cryogenic Technologies (17 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). Étienne Dumont is often cited by papers focused on Rocket and propulsion systems research (36 papers), Spacecraft and Cryogenic Technologies (17 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). Étienne Dumont collaborates with scholars based in United States, United Kingdom and Germany. Étienne Dumont's co-authors include E. Weidekamm, Brigitte Roos, Bruno Reigner, Jim Cassidy, Sarah Durston, Kazushige Mori, Masahiro Utoh, Ludger Banken, Mohammad Sharif Hossain and Courtney Tiffany and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Étienne Dumont

110 papers receiving 1.8k citations

Hit Papers

Preferential activation of capecitabine in tumor followin... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Étienne Dumont United States 19 710 396 244 203 188 118 1.9k
Leona W. Ayers United States 27 298 0.4× 453 1.1× 613 2.5× 133 0.7× 345 1.8× 94 2.3k
Kazuko Yamamoto Japan 22 127 0.2× 356 0.9× 504 2.1× 58 0.3× 107 0.6× 164 1.6k
Yu Lou United States 32 251 0.4× 469 1.2× 718 2.9× 72 0.4× 116 0.6× 131 3.2k
De Chang China 16 171 0.2× 374 0.9× 132 0.5× 18 0.1× 60 0.3× 62 1.4k
David Z. D’Argenio United States 26 326 0.5× 594 1.5× 249 1.0× 12 0.1× 384 2.0× 96 2.3k
Tongyu Zhu China 20 241 0.3× 699 1.8× 181 0.7× 122 0.6× 15 0.1× 52 2.3k
Helmut Ostermann Germany 36 822 1.2× 308 0.8× 1.4k 5.9× 57 0.3× 219 1.2× 134 4.1k
Yoshitaka Yano Japan 23 424 0.6× 332 0.8× 214 0.9× 23 0.1× 465 2.5× 83 1.8k
Marcello Maida Italy 26 559 0.8× 246 0.6× 933 3.8× 53 0.3× 15 0.1× 165 2.4k
F. Lemaı̂tre France 27 548 0.8× 432 1.1× 664 2.7× 17 0.1× 677 3.6× 100 2.3k

Countries citing papers authored by Étienne Dumont

Since Specialization
Citations

This map shows the geographic impact of Étienne Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Étienne Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Étienne Dumont more than expected).

Fields of papers citing papers by Étienne Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Étienne Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Étienne Dumont. The network helps show where Étienne Dumont may publish in the future.

Co-authorship network of co-authors of Étienne Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of Étienne Dumont. A scholar is included among the top collaborators of Étienne Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Étienne Dumont. Étienne Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumont, Étienne, et al.. (2024). The CALLISTO and ReFEx flight experiments at DLR - Challenges and opportunities of a wholistic approach. Acta Astronautica. 225. 417–433. 5 indexed citations
2.
Klevanski, Josef, et al.. (2024). Aerothermal characterization of the CALLISTO vehicle during descent. CEAS Space Journal. 17(4). 529–548. 2 indexed citations
3.
Perry, Caroline, Shaila Shabbir, Maciej J. Zamek‐Gliszczynski, et al.. (2023). Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters. Clinical and Translational Science. 16(4). 647–661. 7 indexed citations
4.
Sagliano, Marco, et al.. (2023). Unified-Loop Structured H-Infinity Control for Aerodynamic Steering of Reusable Rockets. Journal of Guidance Control and Dynamics. 46(5). 815–837. 8 indexed citations
5.
Sagliano, Marco, et al.. (2022). Structured Robust Control for the Aerodynamic Steering of Reusable Rockets. IFAC-PapersOnLine. 55(25). 31–36. 3 indexed citations
6.
Scangarella-Oman, Nicole E., Mohammad Sharif Hossain, Caroline Perry, et al.. (2022). Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sexually Transmitted Infections. 99(1). 64–69. 16 indexed citations
7.
Dumont, Étienne, Josef Klevanski, Bodo Reimann, et al.. (2021). CALLISTO: A Demonstrator for Reusable Launcher Key Technologies. TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES AEROSPACE TECHNOLOGY JAPAN. 19(1). 106–115. 13 indexed citations
8.
Nguyen, Dung N., Jafar Sadik Shaik, Courtney Tiffany, et al.. (2021). Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague. British Journal of Clinical Pharmacology. 88(2). 416–428. 9 indexed citations
9.
Vegvari, Carolin, Yonatan H. Grad, Peter J White, et al.. (2020). Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea. Eurosurveillance. 25(43). 8 indexed citations
10.
Sippel, Martin, et al.. (2018). Assessment of a European Reusable VTVL Booster Stage. elib (German Aerospace Center). 2 indexed citations
11.
Gardner, Stephen D., Jae Bum Kim, Víctor A. López, et al.. (2017). GSK2878175, a pan‐genotypic non‐nucleoside NS5B polymerase inhibitor, in healthy and treatment‐naïve chronic hepatitis C subjects. Journal of Viral Hepatitis. 25(1). 19–27. 10 indexed citations
12.
Adkison, Kimberly K., Stephen D. Gardner, Étienne Dumont, et al.. (2015). Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment. The Journal of Clinical Pharmacology. 55(9). 1042–1050. 2 indexed citations
13.
Zhu, John, Chester L. Bowen, Odin Naderer, et al.. (2014). Investigation of Metabolism and Disposition of GSK1322322, a Peptidase Deformylase Inhibitor, in Healthy Humans Using the Entero-Test for Biliary Sampling. Drug Metabolism and Disposition. 42(8). 1314–1325. 9 indexed citations
14.
Dumont, Étienne, et al.. (2013). A computer-based tool for preliminary design andperformance assessment of Continuous Detonation WaveEngines. elib (German Aerospace Center). 2 indexed citations
15.
Reginster, Jean‐Yves, Dieter Felsenberg, Cyrus Cooper, et al.. (2005). A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporosis International. 17(2). 159–166. 28 indexed citations
16.
Reginster, Jean‐Yves, Katie Wilson, Étienne Dumont, Bernard Bonvoisin, & Joanne Barrett. (2005). Monthly Oral Ibandronate Is Well Tolerated and Efficacious in Postmenopausal Women: Results from the Monthly Oral Pilot Study. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5018–5024. 45 indexed citations
17.
Conti, D, Thomas A. Gonwa, Philip F. Halloran, et al.. (2000). Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics. Clinical Transplantation. 14(3). 179–188. 61 indexed citations
18.
Spina, Edoardo, Eugen Steiner, Étienne Dumont, & R. Dahlqvist. (1989). Inhibition of Desipramine 2-Hydroxylation by Quinidine and Quinine in Rapid and Slow Debrisoquine Hydroxylators. PubMed. 7. 201–205. 7 indexed citations
19.
Dumont, Étienne, Christer von Bahr, Thomas L. Perry, & Leif Bertilsson. (1987). Glucuronidation of the Enantiomers of E‐10‐Hydroxynortriptyline in Human and Rat Liver Microsomes. Pharmacology & Toxicology. 61(5). 335–341. 16 indexed citations
20.
Desager, Jean‐Pierre, Suzanne Pourbaix, Étienne Dumont, & C. Harvengt. (1984). Metabolic Interaction of Cimetidine With Alprazolam and Triazolam After Repeated Doses. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 270(1). 170–170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026